首页> 外文OA文献 >Performance of Risk Estimation for Hepatocellular Carcinoma in Chronic Hepatitis B (REACH-B) score in classifying treatment eligibility under 2012 Asian Pacific Association for the Study of the Liver (APASL) guideline for chronic hepatitis B patients

【2h】

Performance of Risk Estimation for Hepatocellular Carcinoma in Chronic Hepatitis B (REACH-B) score in classifying treatment eligibility under 2012 Asian Pacific Association for the Study of the Liver (APASL) guideline for chronic hepatitis B patients

机译：慢性乙型肝炎肝胆癌风险估算（REACH-B）评分在亚太地区肝（APASL）慢性乙型肝炎患者肝（APASL）指南下的肝硬化协会中的评分

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
T.-M. Chen; C.-C. Chang; P.-T. Huang; C.-F. Wen; C.-C. Lin;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Performance of risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B) score in classifying treatment eligibility under 2012 Asian Pacific Association for the Study of the Liver (APASL) guideline for chronic hepatitis B patients [J] . Alimentary pharmacology & therapeutics. . 2013,第2期

机译：根据2012年亚太太平洋慢性乙肝研究协会（APASL）指南，慢性乙型肝炎肝癌风险评估（REACH-B）评分对治疗资格进行分类的表现
2. Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy [J] . The Journal of Infectious Diseases . 2020,第3期

机译：亚太地区肝脏联盟对HBV风险评分的真实效力，用于预测口腔抗病毒治疗慢性乙型肝炎患者肝细胞癌的肝细胞癌
3. Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy [J] . Yang Hwai- I, Yeh Ming-Lun, Wong Grace L., Autonomic neuroscience: basic & clinical . 2019,第1期

机译：来自亚太地区肝脏联盟的现实世界效力，用于预测口腔抗病毒治疗慢性乙型肝炎患者肝细胞癌预测的HBV风险评分
4. Betatrophin Expression in Chronic Hepatitis C Patients: Does Contribute to Liver Injury-linked Metabolic Syndrome and Hepatocellular Carcinoma Development? [C] . Hendra Susanto, Nan-Shan Liou, Bogi Pratomo, International Conference on Life Sciences and Technology . 2020

机译：慢性丙型肝炎患者的BERATROPHIN表达：是否有助于肝损伤链接代谢综合征和肝细胞癌发育？
5. An exploratory study for the discovery of non-invasive hepatocellular carcinoma biomarkers among high-risk hepatitis C virus infected patients. [D] . Abdalla, Moemen. 2009

机译：在高危丙型肝炎病毒感染患者中发现非侵入性肝细胞癌生物标志物的探索性研究。
6. Summary of the 2nd Asia Pacific Association for the Study of the Liver Diseases (APASL) Autumn Single Topic Conference 2007 The Innovation in Chronic Hepatitis B Treatment [O] . Chutima Pramoolsinsap 2008

机译：第二届亚太肝病研究协会（APASL）2007年秋季单主题会议摘要慢性乙型肝炎治疗的创新
7. Summary of the 2nd Asia Pacific Association for the Study of the Liver Diseases (APASL) Autumn Single Topic Conference 2007 The Innovation in Chronic Hepatitis B Treatment [O] . Pramoolsinsap, Chutima 2008

机译：第二届亚太肝脏疾病研究协会（APASL）2007年秋季单主题会议摘要慢性乙型肝炎治疗的创新

Performance of Risk Estimation for Hepatocellular Carcinoma in Chronic Hepatitis B (REACH-B) score in classifying treatment eligibility under 2012 Asian Pacific Association for the Study of the Liver (APASL) guideline for chronic hepatitis B patients

著录项

引文网络

相似文献

相关主题

期刊订阅